RNO 0.00% 4.0¢ rhinomed limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 49 Posts.
    lightbulb Created with Sketch. 5
    I am somewhat more optimistic about RNO again, let’s hope for profit next quarterly.

    It’d be great to see a partnership with an Australian RAT producer to get Rhinoswab into the retail market in addition to the diagnostics market in the US
    https://www.innovationaus.com/manufacturers-in-limbo-as-local-rats-head-overseas/

    A shame but also seems an export product may be more likely to attract gov manufacturing support
 
watchlist Created with Sketch. Add RNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.